SK Bioscience to start Covid-19 vaccine clinical trials
SK Bioscience’s Covid-19 vaccine candidate NBP2001 has received permission to begin Phase 1 clinical trials. The ministry also gave the green light to Phase 2 clinical trials for Dong Wha Pharm’s Covid-19 treatment candidate, DW2008S.